Other
Brachytherapy
0
Pipeline Programs↗
7
Active Trials↗
0
Companies Involved↗
Brachytherapy is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed6 · 38%
Recruiting4 · 25%
Active, not recruiting2 · 13%
Unknown status2 · 13%
Terminated1 · 6%
Not yet recruiting1 · 6%
Clinical Trials
Trial Activity
16 trials
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Recruiting·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 1·NCT03861676·20 enrolled
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC
Recruiting·SSecond Affiliated Hospital of Guangzhou Medical University·Phase 3·NCT05608213·187 enrolled
Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy
Completed·—·Phase 4·NCT02684942·40 enrolled
Image-Guided Gynecologic Brachytherapy
Completed·—·Phase 2·NCT01399658·93 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)